Spriggs, Melanie K.
Amgen - Seattle Office,
United States
2025 Rank: 82027
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Virology
Rank in SubField 1: 2250 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 82027 | 91483 |
| Total Cites | 8423 | 8954 |
| H-index | 39 | 41 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 390 | 398 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1274 | 1365 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 4469 | 4652 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6668 | 6929 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.29 |
| Self-Citation Percentage |
5.93%
|
|
Spriggs, Melanie K.
Amgen - Seattle Office,
United States
2024 Rank: 76170
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Virology
Rank in SubField 1: 2133 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76170 | 85948 |
| Total Cites | 8237 | 8761 |
| H-index | 39 | 41 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 387 | 395 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1246 | 1333 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 4378 | 4557 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6505 | 6762 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.30 |
| Self-Citation Percentage |
5.98%
|
|
Spriggs, Melanie K.
Amgen - Seattle Office,
United States
2023 Rank: 67586
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Virology
Rank in SubField 1: 1967 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67586 | 77323 |
| Total Cites | 8967 | 9496 |
| H-index | 40 | 41 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 385 | 393 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1229 | 1316 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 4313 | 4492 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6894 | 7148 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.33 |
| Self-Citation Percentage |
5.57%
|
|
Spriggs, Melanie K.
Amgen - Seattle Office,
United States
2022 Rank: 61061
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Virology
Rank in SubField 1: 1840 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61061 | 70149 |
| Total Cites | 8746 | 9272 |
| H-index | 40 | 41 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 384 | 392 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1200 | 1285 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 4221 | 4398 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6700 | 6951 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.33 |
| Self-Citation Percentage |
5.67%
|
|
Spriggs, Melanie K.
Amgen - Seattle Office,
United States
2021 Rank: 58393
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Virology
Rank in SubField 1: 1771 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58393 | 66349 |
| Total Cites | 8600 | 9122 |
| H-index | 39 | 41 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 381 | 389 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1184 | 1269 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 4156 | 4331 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6571 | 6820 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.34 |
| Self-Citation Percentage |
5.72%
|
|
Spriggs, Melanie K.
Amgen - Seattle Office,
United States
2020 Rank: 51296
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Virology
Rank in SubField 1: 1583 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51296 | 59093 |
| Total Cites | 8496 | 9084 |
| H-index | 40 | 41 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 377 | 385 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1165 | 1250 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 4049 | 4223 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6429 | 6707 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.35 |
| Self-Citation Percentage |
6.47%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.